E

Elanco Animal Health
D

ELAN

13.350
USD
-0.06
(-0.41%)
Market Closed
Volume
144,934
EPS
1
Div Yield
-
P/E
33
Market Cap
6,599,609,987
Related Instruments
    AMGN
    AMGN
    -12.22
    (-4.13%)
    294.4 USD
    BIIB
    BIIB
    -4.840
    (-2.94%)
    160.000 USD
    GILD
    GILD
    -3.715
    (-4.03%)
    88.385 USD
    I
    ILMN
    -7.180
    (-5.05%)
    135.110 USD
    I
    INCY
    -1.840
    (-2.37%)
    75.890 USD
    REGN
    REGN
    -25.40
    (-3.25%)
    756.82 USD
    T
    TEVA
    -0.315
    (-1.88%)
    16.440 USD
    VRTX
    VRTX
    -18.53
    (-3.83%)
    450.72 USD
    More
News

Title: Elanco Animal Health

Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Elanco Animal Health is an animal health company that is engaged in developing, manufacturing, and marketing pharma products for companion and food animals. It spun off from Eli Lilly in 2018 and acquired Janssen Animal Health in 2011, Novartis Animal Health in 2014, Boehringer Ingelheim Vetmedica in 2017, and Bayer Animal Health in 2020. The company's operations are conducted globally, and it sells its products in over 90 countries. It offers a range of food animal productsused in cattle, sheep, goats, and swine production.